
Sign up to save your podcasts
Or


Send us Fan Mail
Despite one or two “diet” food brands like Atkins that are still kicking around, diet food innovation is generally a graveyard of CPG innovation. But GLP-1 drugs raise the profile of a different outcome, indirectly supporting weight management - satiety. But are GLP-1 users an innovation segment or a marketing audience? The difference matters, if you’re going to launch a brand with them in mind. And how you do this could steer you right toward, or away from, market leading brands’ GLP-1 innovation efforts. Have a listen to my fresh thoughts.
Your Host: Dr. James F. Richardson of Premium Growth Solutions, LLC www.premiumgrowthsolutions.com
Please send feedback on this or other episodes to: [email protected]
By Dr. James F. Richardson4.9
6565 ratings
Send us Fan Mail
Despite one or two “diet” food brands like Atkins that are still kicking around, diet food innovation is generally a graveyard of CPG innovation. But GLP-1 drugs raise the profile of a different outcome, indirectly supporting weight management - satiety. But are GLP-1 users an innovation segment or a marketing audience? The difference matters, if you’re going to launch a brand with them in mind. And how you do this could steer you right toward, or away from, market leading brands’ GLP-1 innovation efforts. Have a listen to my fresh thoughts.
Your Host: Dr. James F. Richardson of Premium Growth Solutions, LLC www.premiumgrowthsolutions.com
Please send feedback on this or other episodes to: [email protected]

228,335 Listeners

16,076 Listeners

30,248 Listeners

112,279 Listeners

2,679 Listeners

587 Listeners

16,340 Listeners

49 Listeners

2,338 Listeners

1,479 Listeners